[Functional imaging of the brain in the investigation of chronic unexplained pain].

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMID 17378301)

Published in Ned Tijdschr Geneeskd on February 24, 2007

Authors

T J Snijders1, N F Ramsey, J van Gijn

Author Affiliations

1: Universitair Medisch Centrum Utrecht, Rudolf Magnus Institute of Neuroscience, divisie Hersenen, huispostnummer C03.236, Postbus 85.500, 3508 GA Utrecht. t.j.snijders@umcutrecht.nl

Articles by these authors

(truncated to the top 100)

Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72

Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13

Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75

Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67

Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46

[Fever, large eyes and confusion; the anticholinergic syndrome]. Ned Tijdschr Geneeskd (2002) 3.30

[Those who cannot remember the past are condemned to repeat it]. Ned Tijdschr Geneeskd (2006) 2.98

Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69

Nobel laureates' letter to President Bush. Washington Post (2001) 2.43

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39

Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain (2006) 2.35

Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31

Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30

The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 2.29

Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain (1991) 2.18

Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18

Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15

Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14

Carotid endarterectomy with transcranial Doppler and electroencephalographic monitoring. A prospective study in 130 operations. Stroke (1993) 2.13

Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08

The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology (1982) 2.06

Ticlopidine, trials, and torture. Stroke (1994) 2.04

[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03

Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95

Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92

The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89

Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol (1988) 1.89

Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry (1996) 1.87

Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83

Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80

Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet (1988) 1.73

Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73

[On the way to our 200th anniversary]. Ned Tijdschr Geneeskd (2007) 1.72

Spinal infarction. A follow-up study. Stroke (1993) 1.72

Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72

[Diagnostic image (156). A man with a hematoma behind the ear. Mastoid bone fracture]. Ned Tijdschr Geneeskd (2003) 1.69

[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68

Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68

A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67

Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62

Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry (1995) 1.61

Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci (2001) 1.60

Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59

Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54

Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54

[Missing spleen: indication for pneumococcal vaccination]. Ned Tijdschr Geneeskd (2003) 1.53

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke (1988) 1.52

Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet (1994) 1.52

Impact of microembolism and hemodynamic changes in the brain during carotid endarterectomy. Stroke (1994) 1.51

Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet (1993) 1.49

Transient ischaemic attacks and small-vessel disease. Dutch TIA Study Group. Lancet (1991) 1.48

Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med (1984) 1.46

Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol (1985) 1.44

Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke (1989) 1.44

Language lateralization in schizophrenia, an fMRI study. Schizophr Res (2001) 1.41

[Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences]. Ned Tijdschr Geneeskd (2001) 1.41

[Treatment of optic neuritis]. Ned Tijdschr Geneeskd (2004) 1.39

Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry (1998) 1.39

[Medical education: 'plus ça change, plus c'est la même chose']. Ned Tijdschr Geneeskd (1998) 1.39

Yelling attacks and wasted hands. Lancet (1996) 1.39

Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry (1992) 1.38

[On nostalgia and humility]. Ned Tijdschr Geneeskd (1996) 1.38

Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol (1991) 1.38

Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage (2007) 1.36

Risk factors for subarachnoid hemorrhage: a systematic review. Stroke (1996) 1.35

Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. J Neurol Neurosurg Psychiatry (2007) 1.35

Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol (1991) 1.34

Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med (2007) 1.34

Outcome in conversion disorder: a follow up study. J Neurol Neurosurg Psychiatry (1995) 1.34

Spinal dural arteriovenous fistulas: clinical features in 80 patients. J Neurol Neurosurg Psychiatry (2003) 1.33

Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol (2000) 1.32

Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage (2000) 1.32

Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.30

Reproducibility of fMRI-determined language lateralization in individual subjects. Brain Lang (2002) 1.27

Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke (1989) 1.26

Subdural hematoma after lumbar puncture: two case reports and review of the literature. Clin Neurol Neurosurg (1991) 1.25

Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol (1992) 1.23

Atrial fibrillation and the risk of cerebral white matter lesions. Neurology (2000) 1.23

Computerized tomography in subarachnoid hemorrhage: difference between patients with and without an aneurysm on angiography. Neurology (1980) 1.23

Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.23

Measuring quality of life in patients with myocardial infarction or stroke: a feasibility study of four questionnaires in The Netherlands. J Epidemiol Community Health (1995) 1.22

Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol (2002) 1.20

Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke (1984) 1.19

Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 1.19

Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke (1998) 1.19

Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology (2000) 1.16

Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol (1985) 1.16

Familial intracranial aneurysms. A review. Stroke (1992) 1.16

Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2004) 1.16

Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. Stroke (1993) 1.16

Horner's syndrome. Criteria for oculosympathetic denervation. J Neurol Sci (1982) 1.14

Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.13

FMRI-determined language lateralization in patients with unilateral or mixed language dominance according to the Wada test. Neuroimage (2002) 1.12

Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev (2005) 1.12